Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Simple criteria and examples to help you decide which crypto to invest in first, balancing risk with potential rewards for beginners.
27,515 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A Global Partners LP COO sold nearly $740k worth of units in a short window. This article explains what insider trade...
Fluor dropped 26% and headlines lit up. But a solid long-term thesis for this EPC powerhouse requires more than a fla...
A large insider sale at Relay Therapeutics coincides with a dramatic stock rally. This article breaks down what the r...
In early 2026, retirees are increasingly adopting a low-volatility ETF to stabilize portfolios amid ongoing market vo...
Alibaba's profits falling here's headlines grab attention, but the real story is a company in transition. This guide ...
IMAX stock jumped this week as takeover chatter surfaced. This article breaks down the drivers behind the move, what ...
When a chief financial officer sells a large block of stock, investors sit up and take notice. This article breaks do...
As Elanco maps out its path for 2025, investors weigh growth drivers, margins, and catalysts. This guide breaks down ...
When Nasdaq and S&P 500 slip together into correction territory, investors face questions and tough choices. This gui...
A broad market ETF like SCHX hides a sharp concentration at the top. The three largest positions drive about 48% of t...
June 2026 looked like a milestone month for Oklo, but the stock went the other way. This deep dive explains why the s...